Absci Corporation (ABSI) vs Immunome, Inc. (IMNM)
A side-by-side comparison of Absci Corporation and Immunome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABSI
Absci Corporation
$10.71HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
IMNM
Immunome, Inc.
$20.19HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
Total return — ABSI vs IMNM
growth of $100 · dividends reinvested · last 5yABSI -46.6% (-11.8%/yr)IMNM +21.1% (+3.9%/yr)IMNM compounded faster over this window
ABSI IMNM
ABSI vs IMNM: by the numbers
- •IMNM is the larger company ($1.93B vs $1.81B market cap).
- •Both run net losses; IMNM's is the smaller (-3059.99% vs -7756.37% net margin).
Metrics side by side
Valuation
| Metric | ABSI | IMNM |
|---|---|---|
| P/S ratio | 1162.25 | N/A |
| P/B ratio | 7.37 | 3.68 |
Profitability
| Metric | ABSI | IMNM |
|---|---|---|
| Gross margin | -319.36% | 57.43% |
| Operating margin | -4454.21% | -3084.76% |
| Net margin | -7756.37% | -3059.99% |
| ROE | -49.19% | -48.43% |
| ROIC | -52.66% | -51.06% |
Growth (annualized)
| Metric | ABSI | IMNM |
|---|---|---|
| Revenue CAGR (5Y) | -22.08% | N/A |
| Total return CAGR (5Y) | 0.89% | 2.88% |
Frequently asked
- How have ABSI and IMNM total returns compared?
- Over the past 5 years, ABSI delivered 0.89% and IMNM delivered 2.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.